NO20021077D0 - Amino-triazolopyridin-derivater - Google Patents

Amino-triazolopyridin-derivater

Info

Publication number: NO20021077D0
Authority: NO; Norway
Prior art keywords: triazolopyridin; derivatives; amino; triazolopyridin derivatives
Prior art date: 1999-09-06

Application number

NO20021077A

Other languages

English (en)

Other versions

NO20021077L (no

Inventor

Gerda Huber Trottmann

Walter Hunkeler

Roland Jakob-Roetne

Gavin John Kilpatrick

Matthias Heinrich Nettekoven

Claus Riemer

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-06

Filing date

2002-03-05

Publication date

2002-03-05

2002-03-05 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2002-03-05 Publication of NO20021077L publication Critical patent/NO20021077L/no

2002-03-05 Publication of NO20021077D0 publication Critical patent/NO20021077D0/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Addiction (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20021077A 1999-09-06 2002-03-05 Amino-triazolopyridin-derivater NO20021077D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99117578		1999-09-06
PCT/EP2000/008372 WO2001017999A2 (en)	1999-09-06	2000-08-28	Amino-triazolopyridine derivatives

Publications (2)

Publication Number	Publication Date
NO20021077L NO20021077L (no)	2002-03-05
NO20021077D0 true NO20021077D0 (no)	2002-03-05

Family

ID=8238933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021077A NO20021077D0 (no)	1999-09-06	2002-03-05	Amino-triazolopyridin-derivater

Country Status (22)

Country	Link
US (1)	US6355653B1 (no)
EP (1)	EP1214322A2 (no)
JP (1)	JP2003528811A (no)
KR (1)	KR20020027625A (no)
CN (1)	CN1379777A (no)
AR (1)	AR037484A1 (no)
AU (1)	AU7511000A (no)
BR (1)	BR0013792A (no)
CA (1)	CA2383998A1 (no)
CZ (1)	CZ20021220A3 (no)
HR (1)	HRP20020172A2 (no)
HU (1)	HUP0203316A3 (no)
IL (1)	IL148167A0 (no)
MA (1)	MA26816A1 (no)
MX (1)	MXPA02001748A (no)
NO (1)	NO20021077D0 (no)
PE (1)	PE20010629A1 (no)
PL (1)	PL354240A1 (no)
TR (1)	TR200200579T2 (no)
WO (1)	WO2001017999A2 (no)
YU (1)	YU13502A (no)
ZA (1)	ZA200201055B (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6506772B1 (en)	2000-12-15	2003-01-14	Hoffmann-La Roche Inc.	Substituted [1,2,4]triazolo[1,5a]pyridine derivatives with activity as adenosine receptor ligands
US6514989B1 (en) *	2001-07-20	2003-02-04	Hoffmann-La Roche Inc.	Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives
US6693116B2 (en)	2001-10-08	2004-02-17	Hoffmann-La Roche Inc.	Adenosine receptor ligands
JP4101755B2 (ja) *	2001-10-08	2008-06-18	エフ．ホフマン−ラロシュアーゲー	８−アミノ−〔１，２，４〕トリアゾロ〔１，５−ａ〕ピリジン−６−カルボン酸アミド
KR20050044600A (ko)	2001-11-30	2005-05-12	쉐링 코포레이션	[1,2,4]-트리아졸 바이사이클릭 아데노신 Ａ2ａ 수용체길항제
HUP0105407A3 (en) *	2001-12-21	2004-04-28	Sanofi Aventis	Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
EP2260850B1 (en)	2002-01-28	2018-07-04	Kyowa Hakko Kogyo Co., Ltd	A2A receptor antagonists for use in the treatment of movement disorders
WO2003106446A1 (en) *	2002-06-13	2003-12-24	Pfizer Inc.	Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
EP1711498A2 (en) *	2004-01-26	2006-10-18	Altana Pharma AG	1,2,4-triazolo¬1,5-a\|pyridines as gastric acid secretion inhibitors
MX2007007604A (es) *	2004-12-21	2007-08-02	Schering Corp	Antagonistas del receptor de pirazolo[1,5-a]pirimidina adenosina a2a.
ES2273599B1 (es)	2005-10-14	2008-06-01	Universidad De Barcelona	Compuestos para el tratamiento de la fibrilacion auricular.
CA2657247A1 (en) *	2006-07-28	2008-01-31	Boehringer Ingelheim International Gmbh	Compounds which modulate the cb2 receptor
EP2074084B1 (en) *	2006-09-25	2013-08-28	Boehringer Ingelheim International GmbH	Compounds which modulate the cb2 receptor
ZA200904477B (en) *	2006-11-27	2010-09-29	Lundbeck & Co As H	Heteroaryl amide derivatives
JP2010511018A (ja) *	2006-12-01	2010-04-08	ガラパゴス・ナムローゼ・フェンノートシャップ	変性疾患及び炎症性疾患の治療に有用なトリアゾロピリジン化合物
NZ580394A (en) *	2007-04-10	2011-10-28	Lundbeck & Co As H	Heteroaryl amide analogues as p2x7 antagonists
WO2009017954A1 (en) *	2007-08-01	2009-02-05	Phenomix Corporation	Inhibitors of jak2 kinase
GB0719803D0 (en)	2007-10-10	2007-11-21	Cancer Rec Tech Ltd	Therapeutic compounds and their use
CA2704684A1 (en) *	2007-11-07	2009-05-14	Boehringer Ingelheim International Gmbh	Compounds which modulate the cb2 receptor
EP2418207A1 (en) *	2008-05-13	2012-02-15	Boehringer Ingelheim International GmbH	Sulfone compounds which modulate the CB2 receptor
PE20110063A1 (es) *	2008-06-20	2011-02-16	Genentech Inc	DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
CN102131389A (zh) *	2008-06-20	2011-07-20	健泰科生物技术公司	三唑并吡啶jak抑制剂化合物和方法
WO2010005782A1 (en) *	2008-07-10	2010-01-14	Boehringer Ingelheim International Gmbh	Sulfone compounds which modulate the cb2 receptor
TWI453207B (zh) *	2008-09-08	2014-09-21	Signal Pharm Llc	胺基三唑并吡啶，其組合物及使用其之治療方法
CN102164916A (zh) *	2008-09-25	2011-08-24	贝林格尔.英格海姆国际有限公司	选择性调节cb2受体的磺酰基化合物
MY153913A (en) *	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
BRPI1009637A2 (pt)	2009-06-05	2019-04-30	Cephalon, Inc	composto, composição e uso de um composto
US8299103B2 (en) *	2009-06-15	2012-10-30	Boehringer Ingelheim International Gmbh	Compounds which selectively modulate the CB2 receptor
EP2443107B1 (en)	2009-06-16	2018-08-08	Boehringer Ingelheim International GmbH	Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
PE20120629A1 (es) *	2009-07-17	2012-05-30	Japan Tobacco Inc	Compuesto triazolopiridina y su accion como inhibidor de prolil hidroxilasa e inductor de la produccion de eritropoyetina
JP2013505295A (ja) *	2009-09-22	2013-02-14	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｂ２受容体を選択的に調節する化合物
EP2523936A1 (en)	2010-01-15	2012-11-21	Boehringer Ingelheim International GmbH	Compounds which modulate the cb2 receptor
JP5746228B2 (ja)	2010-03-05	2015-07-08	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｂ２受容体を選択的に調節するテトラゾール化合物
US8846936B2 (en)	2010-07-22	2014-09-30	Boehringer Ingelheim International Gmbh	Sulfonyl compounds which modulate the CB2 receptor
UA108711C2 (uk) *	2011-09-19	2015-05-25	Ф. Хоффманн-Ля Рош Аг	Сполуки триазолопіридину як інгібітори фосфодіестерази pde10a
WO2013043518A1 (en)	2011-09-22	2013-03-28	Merck Sharp & Dohme Corp.	Imidazopyridyl compounds as aldosterone synthase inhibitors
EP2757883B1 (en)	2011-09-22	2021-01-13	Merck Sharp & Dohme Corp.	Triazolopyridyl compounds as aldosterone synthase inhibitors
EP2803668A1 (en)	2013-05-17	2014-11-19	Boehringer Ingelheim International Gmbh	Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
BR112018068681A2 (pt)	2016-03-16	2019-01-15	Bayer Cropscience Ag	derivados de n-(cianobenzil)-6-(ciclopropil-carbonilamino)-4-(fenil)-piridina-2-carboxamida e compostos relacionados como pesticidas e agentes de proteção de plantas
CN106543175B (zh) *	2016-10-28	2018-06-01	上海大学	三芳基[1,2,4]三氮唑[1,5-a]吡啶衍生物及其制备方法
JP7111733B2 (ja) *	2017-03-16	2022-08-02	江蘇恒瑞医薬股▲ふん▼有限公司	ヘテロアリール［４，３－ｃ］ピリミジン－５－アミン誘導体、その製造方法、およびその医薬の使用
CR20200441A (es)	2018-02-27	2021-03-15	Incyte Corp	Imidazopirimidinas y triazolopirimidinas como inhibidores de a2a / a2b
MX2020012376A (es) *	2018-05-18	2021-03-09	Incyte Corp	Derivados de pirimidina fusionados como inhibidores de los receptores de adenosina a2a/a2b.
IL279829B2 (en)	2018-07-05	2025-05-01	Incyte Holdings Corp	Fused pyrazine derivatives as A2A/A2B inhibitors
WO2020054712A1 (ja) *	2018-09-12	2020-03-19	日本化薬株式会社	有害生物防除剤
BR112021011948A2 (pt)	2018-12-20	2021-09-08	Incyte Corporation	Compostos de imidazopiridazina e imidazopiridina e usos dos mesmos
TWI829857B (zh)	2019-01-29	2024-01-21	美商英塞特公司	作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
US20230167119A1 (en) *	2021-01-09	2023-06-01	Bugworks Research, Inc.	Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2a receptor and adenosine 2b receptor antagonist
CN116082335A (zh) *	2023-01-16	2023-05-09	上海凌凯医药科技有限公司	一种二芳基醚化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9226735D0 (en)	1992-12-22	1993-02-17	Ici Plc	Azole derivatives
AU2639299A (en)	1998-02-24	1999-09-15	Kyowa Hakko Kogyo Co. Ltd.	Remedies/preventives for parkinson's disease

2000
- 2000-08-24 US US09/645,127 patent/US6355653B1/en not_active Expired - Fee Related
- 2000-08-28 EP EP00964043A patent/EP1214322A2/en not_active Withdrawn
- 2000-08-28 TR TR2002/00579T patent/TR200200579T2/xx unknown
- 2000-08-28 HR HR20020172A patent/HRP20020172A2/hr not_active Application Discontinuation
- 2000-08-28 HU HU0203316A patent/HUP0203316A3/hu unknown
- 2000-08-28 WO PCT/EP2000/008372 patent/WO2001017999A2/en not_active Ceased
- 2000-08-28 CN CN00812501A patent/CN1379777A/zh active Pending
- 2000-08-28 PL PL00354240A patent/PL354240A1/xx not_active Application Discontinuation
- 2000-08-28 JP JP2001522222A patent/JP2003528811A/ja active Pending
- 2000-08-28 MX MXPA02001748A patent/MXPA02001748A/es unknown
- 2000-08-28 CZ CZ20021220A patent/CZ20021220A3/cs unknown
- 2000-08-28 CA CA002383998A patent/CA2383998A1/en not_active Abandoned
- 2000-08-28 KR KR1020027002990A patent/KR20020027625A/ko not_active Ceased
- 2000-08-28 IL IL14816700A patent/IL148167A0/xx unknown
- 2000-08-28 BR BR0013792-8A patent/BR0013792A/pt not_active IP Right Cessation
- 2000-08-28 YU YU13502A patent/YU13502A/sh unknown
- 2000-08-28 AU AU75110/00A patent/AU7511000A/en not_active Abandoned
- 2000-09-04 PE PE2000000903A patent/PE20010629A1/es not_active Application Discontinuation
- 2000-09-04 AR ARP000104612A patent/AR037484A1/es not_active Application Discontinuation
2002
- 2002-02-06 ZA ZA200201055A patent/ZA200201055B/xx unknown
- 2002-03-05 NO NO20021077A patent/NO20021077D0/no not_active Application Discontinuation
- 2002-03-06 MA MA26540A patent/MA26816A1/fr unknown

Also Published As

Publication number	Publication date
IL148167A0 (en)	2002-09-12
ZA200201055B (en)	2003-07-30
HRP20020172A2 (en)	2003-10-31
NO20021077L (no)	2002-03-05
PE20010629A1 (es)	2001-05-30
AU7511000A (en)	2001-04-10
EP1214322A2 (en)	2002-06-19
CN1379777A (zh)	2002-11-13
CZ20021220A3 (cs)	2002-10-16
PL354240A1 (en)	2003-12-29
HUP0203316A2 (hu)	2003-01-28
TR200200579T2 (tr)	2002-12-23
JP2003528811A (ja)	2003-09-30
MXPA02001748A (es)	2002-08-06
WO2001017999A2 (en)	2001-03-15
MA26816A1 (fr)	2004-12-20
HUP0203316A3 (en)	2004-07-28
WO2001017999A3 (en)	2001-12-06
AR037484A1 (es)	2004-11-17
YU13502A (sh)	2004-11-25
US6355653B1 (en)	2002-03-12
CA2383998A1 (en)	2001-03-15
BR0013792A (pt)	2002-05-14
KR20020027625A (ko)	2002-04-13

Publication	Publication Date	Title
NO20000885L (no)	2000-08-25	4-Fenyl-pyridin-derivater
NO20021077D0 (no)	2002-03-05	Amino-triazolopyridin-derivater
ATE263748T1 (de)	2004-04-15	Admantan-derivate
DE50010060D1 (de)	2005-05-19	Thiazolylamid-derivate
IS6128A (is)	2001-10-26	13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da)	2004-12-20	5-phenyl-pyrimidinderivater
DE50013404D1 (de)	2006-10-12	Substituierte 2-dialkylaminoalkylbiphenyl-derivate
NO20021803L (no)	2002-06-17	Isoksazolkarboksamid-derivater
PT1237857E (pt)	2004-10-29	Novos derivados fenalquiloxi-fenilo
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
DK1154988T3 (da)	2004-11-22	Mevinolinderivater
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
ATE254598T1 (de)	2003-12-15	4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de)	2005-05-15	Resorcinderivate
DK1187815T3 (da)	2006-06-19	4-phenyl-pyrimidinderivater
TR200002831A3 (tr)	2001-04-20	Kinolin-4-Il türevleri I
DK1189886T3 (da)	2006-05-15	Ethansulfonyl-piperidinderivater
NO20022867D0 (no)	2002-06-14	Syklopentenon-derivater
NO20020212L (no)	2002-01-15	3-amino-2-benzyl-1-fenyl-propanderivater
PT1194401E (pt)	2004-02-27	Derivados de diacil-hidrazina
DE60001736D1 (de)	2003-04-24	1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
ATE269328T1 (de)	2004-07-15	1-cycloalkylpyrazolyl-benzoyl-derivate

Legal Events

Date	Code	Title	Description
2005-05-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application